tiprankstipranks
Augmedix (AUGX)
NASDAQ:AUGX
US Market

Augmedix (AUGX) Financial Statements

68 Followers

Augmedix Financial Overview

Augmedix's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Augmedix is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 12.68M$ 11.77M$ 10.78M$ 9.63M$ 8.75M
Gross Profit$ 6.25M$ 5.83M$ 10.78M$ 4.39M$ 4.05M
EBIT$ 601.00K$ -3.68M$ -4.42M$ -4.80M$ -5.27M
EBITDA$ 5.67M$ -2.61M$ -3.99M$ -5.10M$ -5.27M
Net Income Common Stockholders$ -4.49M$ -4.41M$ -5.03M$ 24.27M$ -5.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 46.22M$ 21.59M$ 24.68M$ 20.60M$ 21.71M
Total Assets$ 66.71M$ 40.83M$ 43.85M$ 33.07M$ 33.64M
Total Debt$ 25.85M$ 23.62M$ 23.84M$ 22.35M$ 16.97M
Net Debt$ -20.37M$ 2.03M$ -836.00K$ 1.75M$ -4.74M
Total Liabilities$ 43.39M$ 40.10M$ 39.86M$ 36.26M$ 32.17M
Stockholders Equity$ 23.32M$ 734.00K$ 3.99M$ -3.19M$ 1.47M
Cash Flow-
Free Cash Flow$ -2.17M$ -2.73M$ -7.20M$ -6.46M$ -4.98M
Operating Cash Flow$ -973.00K$ -2.29M$ -5.89M$ -6.28M$ -4.39M
Investing Cash Flow$ -1.19M$ -437.00K$ -1.30M$ -173.00K$ -592.00K
Financing Cash Flow$ 26.38M$ 20.00K$ 11.88M$ 5.08M$ 7.00K
Currency in USD

Augmedix Earnings and Revenue History

Augmedix Debt to Assets

Augmedix Cash Flow

Augmedix Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis